Related content

Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

By Mulders T.M.T.   Dieben T.O.M.  

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 865-870

Elsevier

Access to resources Recommend Favorite

The combined contraceptive vaginal device (NuvaRing®): A comprehensive review

By Sarkar NN  

The European Journal of Contraception and Reproductive Health Care, Vol. 10, Iss. 2, 2005-06 ,pp. : 73-78

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms

By Speroff L.   United States VR Investigator Group  

Obstetrics and Gynecology, Vol. 102, Iss. 4, 2003-10 ,pp. : 823-834

Elsevier

Access to resources Recommend Favorite

Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use

By Merki-Feld Gabriele S.   Hund Martin  

The European Journal of Contraception and Reproductive Health Care, Vol. 15, Iss. 6, 2010-12 ,pp. : 413-422

Informa Healthcare

Access to resources Recommend Favorite

The combined contraceptive vaginal ring (NuvaRing®): First experience in daily clinical practice in The Netherlands

By Roumen Frans   Berg Monique M. T. op ten   Hoomans Eric  

The European Journal of Contraception and Reproductive Health Care, Vol. 11, Iss. 1, 2006-03 ,pp. : 14-22

Informa Healthcare

Access to resources Recommend Favorite